You are here

Article info

Article menu

Download PDFPDF

Commentary
FAK-inhibition opens the door to checkpoint immunotherapy in Pancreatic Cancer

Authors

  • Stefan N. Symeonides Edinburgh Cancer Research UK Centre, Institute of Genetics and Molecular MedicineUniversity of Edinburgh EH4 2XR Edinburgh UK PubMed articlesGoogle scholar articles
  • Stephen M. Anderton MRC Centre for Inflammation Research, The Queen’s Medical Research InstituteUniversity of Edinburgh EH16 4TJ Edinburgh UK PubMed articlesGoogle scholar articles
  • Alan Serrels MRC Centre for Inflammation Research, The Queen’s Medical Research InstituteUniversity of Edinburgh EH16 4TJ Edinburgh UK Edinburgh Cancer Research UK Centre, Institute of Genetics and Molecular MedicineUniversity of Edinburgh EH4 2XR Edinburgh UK PubMed articlesGoogle scholar articles
  1. ↵a +44-131-242-9198 Stefan.Symeonides{at}ed.ac.uk
  2. ↵b +44-131-242-9198 Steve.Anderton{at}ed.ac.uk
  3. ↵c +44-131-242-9198 a.serrels{at}ed.ac.uk
View Full Text

Citation

Symeonides SN, Anderton SM, Serrels A
FAK-inhibition opens the door to checkpoint immunotherapy in Pancreatic Cancer
Journal for ImmunoTherapy of Cancer 2017;5:17. doi: 10.1186/s40425-017-0217-6

Publication history

  • Received November 3, 2016
  • Accepted February 1, 2017
  • First published February 21, 2017.
Online issue publication 
February 21, 2017

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© The Author(s). Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.